ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
ATOSSA THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.56−0.35 (-12.03%)
Close on Oct 19, 2026
- Market cap
- $22.81M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Atossa Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 8, 2026 | Oct 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 18, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2026 | Aug 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 16, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 20, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 19, 2025 | Dec 22, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 26, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2025 | Sep 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2025 | Aug 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 26, 2025 | Mar 26, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2025 | Feb 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2025 | Feb 4, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 10, 2024 | SEC EDGAR |